The online sales and distribution of products commenced this week in South Africa.
By Edward Tsumele, Cannabis Business Africa/CBA Editor
Psyence Group Inc. a public life science biotechnology company listed on the Canadian Securities Exchange (CSE: PSYG), sets the global standard for natural psychedelics . The biotechnology company pioneers the use of natural psychedelics in mental health and well-being. This deal was announced this week, with the immediate commencement of online sales and distribution of its premium range of functional mushroom products, branded Good mind in South Africa.
The products regarded as complimentary medicines in South Africa have to meet the requirements set by the South African Health regulatory Authority (SAHPRA) for such category of medicine.
Psyence Group Inc revealed that the Goodmind formulas harness the power of adaptogens; non-toxic, non-psychoactive fungi, used for centuries in traditional medicine for their stress-relieving benefits.
“Goodmind is designed to nourish the mind and elevate everyday life by enhancing mental capacity and the body’s ability to adapt to stress,” the company said in a statement this week.
Psyence has partnered with Goodleaf, a leading cannabis wellness and lifestyle brand with a premium range of products infused with African botanicals. Their products exist to enhance emotional wellbeing through inspiring acts of self-care, routine and habit that can enhance quality of life, every day.
GoodLeaf has in recent years of its existence cornered the local cannabis lifestyle premium market with a wide range of their products. Their product offering includes oils, skincare topicals, CBD infused sparkling drinks, natural vapes and powder sachets. Goodleaf products are available in South Africa from their three retail stores, their own online store as well as from leading brands such as Woolworths, Superbalist, Wellness Warehouse, Vida e Caffè and Poetry. CBD beverages are available at over 1,000 outlets across South Africa including Spar, Pick ‘n Pay, Checkers and Clicks. Goodleaf products will soon be available in the UK in selected UK stores as well as Amazon UK.
“Goodleaf has demonstrated great competence in launching new consumer goods in an emerging industry. Psyence is experienced in product development, scientific research, procurement, manufacturing, and logistics. Both companies intend to leverage their knowledge and experience in the nutraceutical and supplement industry to create class-leading products in the functional mushroom space,” both companies said.
Neil Maresky, Chief Executive Officer, Psyence Group Inc. says: “We are delighted that our first nutraceutical product, GOODMIND™, is now available for sale online in South Africa. This is an important milestone for Psyence as we look to grow our over-the-counter nutraceutical wellness collection. Goodleaf has a proven track record of successfully launching and distributing high-quality products and we believe they are an excellent partner to successfully launch GOODMIND™ in this growing market.”
“Our experience in developing and launching new consumer products will be invaluable as we make headway in the functional mushroom space. There is no doubt that there is a growing demand for wellness products, and we are extremely excited to collaborate with Psyence, as we launch Goodmind and bring a range of functional mushroom products to market,” says Warren Schewitz, Founder and Chief Executive Officer of Goodleaf.